Kim Forest Enterprise Co., Ltd. Stock

Equities

6645

TW0006645005

Biotechnology & Medical Research

End-of-day quote Taiwan S.E. 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
38 TWD +1.06% Intraday chart for Kim Forest Enterprise Co., Ltd. -1.55% +2.98%
Sales 2022 671M 20.62M Sales 2023 415M 12.76M Capitalization 1.7B 52.18M
Net income 2022 43M 1.32M Net income 2023 -102M -3.14M EV / Sales 2022 2.09 x
Net Debt 2022 1.67M 51.37K Net Debt 2023 24.02M 738K EV / Sales 2023 4.15 x
P/E ratio 2022
32.8 x
P/E ratio 2023
-16.6 x
Employees -
Yield 2022
0.29%
Yield 2023
-
Free-Float 52.03%
More Fundamentals * Assessed data
Dynamic Chart
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Kim Forest Enterprise Co., Ltd.(TWSE:6645) added to Taiwan TAIEX Index CI
Kim Forest Enterprise Co., Ltd. Appoints Daniel Huang as Chief Executive Officer CI
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Kim Forest's H1 Profit Rockets 148% as Revenue Hits Record-High MT
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019 CI
Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018 CI
More news
1 day+1.06%
1 week-1.55%
Current month-1.17%
1 month-3.92%
3 months+7.04%
6 months-20.08%
Current year+2.98%
More quotes
1 week
37.10
Extreme 37.1
38.90
1 month
36.80
Extreme 36.8
40.60
Current year
35.10
Extreme 35.1
47.40
1 year
29.26
Extreme 29.2613
52.90
3 years
18.37
Extreme 18.3713
54.76
5 years
8.69
Extreme 8.687
128.70
10 years
8.69
Extreme 8.687
128.70
More quotes
Managers TitleAgeSince
Chief Executive Officer - 05-06-30
Director of Finance/CFO - 13-12-01
Chief Tech/Sci/R&D Officer - 16-10-31
Members of the board TitleAgeSince
Director/Board Member - 20-06-28
Chief Executive Officer - 05-06-30
Director/Board Member - 04-07-27
More insiders
Date Price Change Volume
24-04-18 38 +1.06% 56,342
24-04-17 37.6 +0.80% 47,000
24-04-16 37.3 -1.58% 52,553
24-04-15 37.9 -1.04% 95,401
24-04-12 38.3 -0.78% 22,845

End-of-day quote Taiwan S.E., April 17, 2024

More quotes
KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
Calendar
More about the company